Dr Shigenobu Suzuki Optalmiese Onkologie

Dr. Shigenobu Suzuki is een van die top-oogkankerspesialiste in Tokio, Japan.

Dr Shigenobu Suzuki is verbonde aan die National Cancer Center Hospital, Japan.

The Department of Ocular Oncology is one of the rare groups specializing in ocular tumors, especially intraocular tumors. Recently, more than 70% of patients nationwide with retinoblastoom, which is the most frequent intraocular malignancy in childhood, and more than 50% of patients with choroidal melanoma, which is the most frequent primary intraocular malignancy in adults, have been referred to our department. We also treat ocular adnexal tumors. More than 350 operations have been done annually.

Ons neem deel aan kliniese proewe deur okulêre nadelige gebeurtenisse van sistemiese chemoterapie te skat. Onlangse molekulêre teikenterapie veroorsaak soms makulêre edeem, sereuse retinale loslating, uveïtis, okulêre oppervlaksiekte, ensovoorts, en ons evalueer en behandel hierdie nadelige gebeurtenisse om kliniese proewe by te dra.

• Optalmiese Onkologie

• Optalmiese Onkologie
• Retinoblastoma
• Makulêre edeem
• Choroidal melanoom